A landmark 2023 study in Science found that taurine deficiency drives aging across species, and supplementation extended healthy lifespan in mice and worms.
In June 2023, a paper published in Science — one of the two most prestigious scientific journals in the world — sent ripples through the longevity community. The study, led by Vijay Yadav at Columbia University, proposed that declining levels of a single amino acid called taurine may be a direct driver of the aging process across multiple species. This is a bold claim, but it rests on a remarkably thorough body of experimental evidence that spans worms, mice, and humans.
Taurine (2-aminoethanesulfonic acid) is a conditionally essential amino acid found abundantly in the brain, heart, eyes, and skeletal muscle. Unlike most amino acids, taurine is not incorporated into proteins; instead it acts as a free amino acid with a range of cellular functions. It regulates osmosis, modulates calcium signalling, suppresses inflammation, acts as an antioxidant, and stabilises cell membranes. Taurine is synthesised endogenously from methionine and cysteine, but production capacity declines with age. It is also obtained from the diet — meat, fish, and dairy are rich sources, which is why vegans often have lower plasma taurine levels.
Despite its importance, taurine has historically been viewed primarily as a component of energy drinks rather than a serious longevity candidate. The 2023 Science paper changed that perception overnight. Energy drink manufacturers had included taurine largely because of its role in muscle function and neurological signalling, without necessarily appreciating the depth of its involvement in the aging process. The research by Yadav and colleagues reframed taurine as something far more fundamental.
Yadav and colleagues made several interconnected observations that, taken together, build a compelling case:
1. Taurine levels decline with age across species. The team measured taurine in blood from humans aged 5-80, as well as in mice and non-human primates (rhesus monkeys) at various ages. In all three species, blood taurine declined substantially with age — roughly 80% lower in older humans compared to young adults. This is a striking convergence across distantly related species that strongly suggests taurine decline is an evolutionarily conserved feature of aging biology, not a coincidence.
2. Taurine supplementation extended lifespan in model organisms. Supplementing C. elegans (roundworms) with taurine extended median lifespan by approximately 10-23% depending on the experimental conditions. In middle-aged mice given taurine daily in their drinking water for one year, median lifespan was extended by 10-12% in both males and females. This is a meaningful extension — equivalent to adding roughly 7-8 years to a human lifespan if the effect translated proportionally.
3. Healthspan improved across multiple measures. Taurine-supplemented mice had better bone density, stronger muscles, less age-related weight gain, lower fasting glucose, reduced DNA damage, less cellular senescence, and improved immune function compared to controls. These are not trivial or isolated benefits — they represent improvements across multiple hallmarks of aging simultaneously.
4. Human data correlated taurine with health outcomes. In a cross-sectional analysis of 12,000 European adults from the EPIC study, higher serum taurine levels were associated with lower BMI, lower fasting glucose, less hypertension, and reduced inflammatory markers. These are associations, not causation, but they are consistent with the mechanistic and animal evidence.
The paper proposes several mechanisms through which taurine deficiency might accelerate aging:
Mitochondrial dysfunction: Taurine is required for proper mitochondrial tRNA modification — specifically, it modifies the wobble uridine position in the anticodon loop of mitochondrial tRNAs. Without adequate taurine, mitochondrial protein synthesis is impaired, reducing energy production and increasing oxidative stress. This is one of the most mechanistically compelling aspects of the Yadav paper because it connects taurine directly to mitochondrial function, one of the most established hallmarks of aging.
Cellular senescence: Taurine supplementation reduced the accumulation of senescent cells — the "zombie cells" that contribute to chronic inflammation and tissue dysfunction with age. Senescent cells are a major target of current longevity research, and reducing their burden has been shown to extend healthspan in multiple animal models.
Epigenetic ageing: Taurine-supplemented mice showed slower epigenetic ageing as measured by DNA methylation clocks — the most widely used molecular measure of biological age. This suggests taurine is not merely masking symptoms of aging but may be influencing the underlying epigenetic program that drives biological age.
Inflammation suppression: Lower taurine was associated with higher inflammatory markers; supplementation suppressed chronic low-grade inflammation, which is increasingly recognised as a central driver of aging and age-related disease.
Telomere maintenance: The study found that taurine-supplemented animals had better telomere length maintenance — longer telomeres are associated with younger biological age and reduced disease risk.
The mouse study used approximately 1,000 mg/kg of body weight per day in drinking water — a dose that does not directly translate to human supplementation. However, common human doses studied in existing clinical trials for heart failure, diabetes, and athletic performance have ranged from 500 mg to 3,000 mg per day and have consistently shown a favourable safety profile.
Several longevity-focused physicians have begun recommending 1,000-2,000 mg/day based on the 2023 findings, reasoning that this dose is well within the human safety envelope while potentially providing meaningful benefits if the animal results translate.
For taurine supplementation, look for unflavoured powder or capsules from reputable brands like NOW Foods Taurine or Thorne Taurine. Powder is the most cost-effective option — Bulk Supplements Taurine powder provides a large quantity at a low per-gram cost, typically under $0.10 per gram.
Peter Attia discussed the paper in detail on The Drive podcast, calling it "one of the more interesting aging papers of the year" but cautioning that the human evidence remains correlational. He noted that the multi-species convergence of taurine decline with age is compelling, but that we need randomised controlled trials in humans to confirm causal benefit. He also highlighted the mitochondrial tRNA mechanism as biologically plausible.
Rhonda Patrick highlighted the mitochondrial tRNA connection on her FoundMyFitness platform, noting that impaired mitochondrial translation is a mechanism with strong theoretical links to aging biology. She also observed that taurine's role in reducing senescent cell burden connects it to one of the most active research areas in geroscience.
David Sinclair of Harvard Medical School, whose research focuses on NAD+ and sirtuins, noted that the multi-hallmark nature of taurine's benefits — improving multiple aging phenotypes simultaneously — is exactly the kind of signature one expects from a genuinely geroprotective intervention rather than a targeted symptom-reducer.
Taurine's profile is interesting when compared to other popular longevity supplements. Unlike NMN and NR (which target NAD+ specifically), taurine appears to work through multiple parallel mechanisms. Unlike rapamycin (which broadly inhibits mTOR), taurine has no known immunosuppressive effects at dietary doses. Unlike metformin (which affects glucose metabolism primarily), taurine appears to have cardiovascular, mitochondrial, neurological, and senolytic effects simultaneously.
This multi-mechanism profile — if confirmed in humans — would make taurine unusually valuable in a comprehensive longevity stack. Its safety record is excellent; it has been studied in clinical trials involving heart failure patients, athletes, and metabolic syndrome subjects for decades without serious adverse events.
The 2023 paper is impressive but not definitive. Several questions remain open:
Given the strong mechanistic rationale, multi-species evidence, and favourable safety profile of taurine, supplementation appears to be a reasonable consideration for longevity-focused individuals, particularly those with low dietary taurine intake (such as vegans and vegetarians). A dose of 1,000-2,000 mg/day, taken with food, aligns with existing human safety data and provides reasonable coverage based on the animal evidence.
As always, this should be combined with the lifestyle fundamentals — regular aerobic exercise, resistance training, adequate sleep, and a nutrient-dense diet — that have far stronger human evidence for longevity benefit. Taurine is a potentially valuable addition to a comprehensive protocol, not a replacement for foundational health practices.